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In this paper, we explore the emergence of non-communicable diseases (NCDs) as an object of political
concern in and for countries of the global South. While epidemiologists and public health practitioners
and scholars have long expressed concern with the changing global distribution of the burden of NCDs, it
is only in more recent years that the aetiology, politics and consequences of these shifts have become an
object of critical social scientiﬁc enquiry. These shifts mark the starting point for this special issue on ‘The
Politics of NCDs in the Global South’ and act as the basis for new, critical interventions in how we un-
derstand NCDs. In this paper, we aim not only to introduce and contextualise the six contributions that
form this special issue, but also to identify and explore three themes – problematisation, care and culture
– that index the main areas of analytical and empirical concern that have motivated analyses of NCDs in
the global South and are central to critical engagement with their political contours.
& 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Over the last 10 years, concern has been mounting over rapid
rises in the prevalence of non-communicable diseases (NCDs) in
the global South and the health and economic burden they re-
present. This has been driven, in part, by the World Health Orga-
nisation (WHO) which has published a number of reports on the
topic and most recently adopted a Global Action Plan for the Pre-
vention and Control of Noncommunicable Diseases 2013–2020
(WHO, 2010; WHO, 2013). The World Bank and the United Nations
Development Programme (UNDP) – two of the leading organisa-
tions in international development – have also been active and
issued discussion and policy papers about ‘the mounting danger of
chronic diseases’ for emerging economies (World Bank, 2011;
UNDP, 2013). Governments, too, have expressed their alarm over
this rising threat, recently passing a Political Declaration on the
Prevention and Control of Non-Communicable Diseases at a high-
level meeting of the United Nations' General Assembly, the second
of only two such meetings held about health (United Nations,
2011). Of course, this attention to chronic diseases in the global
South has not been the sole preserve of international organisations
and governments. Public health and medical experts have long
called for more attention to be paid to NCDs in this region. For
example, one of the leading voices in the global health community,r Ltd. This is an open access article
,
.ac.uk (T. Brown).The Lancet, has published regular special issues with research on
the epidemiological, economic and clinical aspects of chronic
diseases since 2005 (e.g. Horton, 2005; Beaglehole and Horton,
2010; Geneau et al., 2010). Likewise, civil society and the private
sector are showing a growing interest in the subject. Most sig-
niﬁcantly, in 2010, over two thousand health charities and patient
organisations including the American Cancer Society and the
World Heart Federation established, with support from the phar-
maceutical industry, the NCD Alliance to lobby for and make
chronic diseases a global health and development priority (Heath,
2011).
As these different actors have repeatedly argued, NCDs – de-
ﬁned in this context as comprising four conditions (cardiovascular
disease, cancer, diabetes and chronic respiratory disorders) over-
whelmingly caused by four behavioural risk factors (diet, physical
activity, smoking and alcohol) – have become a critical issue for
low and middle income countries (LMICs). Drawing on sophisti-
cated epidemiological data, they point out that more than 60% of
deaths worldwide are NCD-related and nearly 80% of these deaths
occur in LMICs (WHO, 2010; UNDP, 2013). Indeed, in most coun-
tries across South America and Asia, chronic diseases are now the
leading cause of death. Only in the African region are there more
deaths from infectious diseases and even that is predicted to
change over the next 15 years. This high prevalence of NCDs across
the global South, these actors argue, constitutes ‘one of the major
challenges for development in the 21st century’ (United Nations,
2011, p.1). As they explain, the relationship between chronic dis-
eases and development is two-fold (World Bank, 2011; Alleyne
et al., 2013; UNDP, 2013). On the one hand, the growing prevalenceunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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sequence of socio-economic development, with economic growth
and rapid urbanisation associated with a rise in ‘modern’ lifestyles
(drinking, smoking, unhealthy diets, and physical inactivity) and
an ageing population. On the other hand, the chronic disease
epidemic in the global South is understood to be a serious threat
to the sustainability of development through both its negative
impact on the productivity of working age populations and the
double burden of disease it places on health systems already
overstretched by infectious, maternal and perinatal diseases. Pre-
dictably perhaps, many of the solutions put forward by these ac-
tors are health strategies successfully used in North America and
Europe and which are deemed commensurate with the economic
context of LMICs (Yach et al., 2006; Lim et al., 2007; Alwan et al.,
2010; WHO, 2013). They include tools such as epidemiological
surveillance systems as well as public health and clinical inter-
ventions that are ‘highly cost-effective cheap, feasible and cultu-
rally acceptable’ such as tobacco taxation, media campaigns for
healthy diets and multidrug regimens for people at risk of cardi-
ovascular diseases (WHO, 2010, p.47).
There has been no lack of academic attention given to the issue
of NCDs in the global South from the public health community
(Alleyne et al., 2011; Clark, 2014; Marrero et al., 2012; Stuckler and
Basu, 2013). In contrast, critical social science engagements are
comparatively rare, although interesting work has recently begun
to emerge. For example, political scientists have examined the
reasons behind the relative neglect of NCDs in global health policy
and funding compared to issues like AIDS, pointing to the expert
and advocacy networks involved and the ways issues are framed
(e.g. Magnusson, 2007; Jönsson, 2014; cf. also Shiffman, 2009).
Similarly, historians and others have started to explore the glo-
balisation of chronic diseases and particular public health strate-
gies like tobacco taxes over the last 50 years (e.g. Brown and Bell,
2008; Reubi, 2013; Weisz, 2014b). Another important part of this
emerging body of work is the research carried out by anthro-
pologists and geographers into the way ideas and practices asso-
ciated with NCDs have been translated, resisted and re-appro-
priated when travelling to the global South. To illustrate, Living-
ston (2012, 2013) has pointed to the absence of pain relief medi-
cation and the very different understandings of pain in cancer
wards in Botswana; while Lawhon and Herrick (2013; cf. also
Herrick, 2013) have shown how alcohol control policies in Cape
Town have been recast as an instrument to ﬁght criminality rather
than improve health. Others have looked into how the ideas and
practices associated with NCDs have transformed subjectivities
and notions of patienthood in the global South (e.g. Bunkenborg,
2003; Whyte, 2013; Whitmarsh, 2013; cf. also Whyte, 2012).
While this emerging body of critical studies on NCDs in the
global South is a step in the right direction, much more needs to be
done before we can start making sense of current initiatives to
problematise and govern the chronic disease epidemic in emer-
ging economies. So, for example, while the role of expert networks
and discursive framings in problematising NCDs in the global
South needs to be further scrutinised, we also need to explore the
technologies and materialities like epidemiological maps and
models that make it possible to view chronic diseases as a devel-
opment issue. Likewise, while the inﬂuence of the tobacco, alcohol
and food companies in globalising risk factors associated with
NCDs is at risk of being over-analysed (e.g. Yach and Bettcher,
2000; Stuckler and Siegel, 2011), we know very little about the
role of the pharmaceutical industry and philanthropic foundations
in creating new markets for vaccines and drugs to treat chronic
diseases in the region (e.g. Wailoo et al., 2010; Towghi, 2013; cf.
also Petryna et al., 2006). It would also be helpful to know more
about the complex relationships that exist between current in-
itiatives to tackle NCDs and ideas and traditions that have beencritical to the ﬁeld of health and medicine such as post-colonial-
ism, neoliberalism and securitisation (Collier and Lakoff, 2008;
Elbe, 2010; Anderson, 2014). Last but not least, despite the efforts
of some anthropologists (e.g. Livingston, 2005, 2008), we still
understand very little about the impact of NCD-related interven-
tions on existing inequalities and the everyday lives of the poor in
the global South (Farmer, 2005). More generally, then, there is a
need to know more about the types of places that produce chronic
diseases in the global South and, in turn, the ways in which the
politics of NCDs reform and reshape places and people in the name
of risk management and disease control.
The contributions in this special issue are an attempt to begin
addressing these and other similar questions and themes. To locate
these contributions within the broader critical social science lit-
erature on global health (e.g. Collier and Lakoff, 2008; Elbe, 2010;
Weir and Mykhalovskiy, 2010; Stuckler and Siegel, 2011; Fassin,
2012; Farmer et al., 2013; Biehl and Petryna, 2013; Anderson, 2014),
this introduction outlines three themes that, we believe, are central
to a critical engagement with the politics of NCDs in the global
South. First, an attention to ‘problematisation’ is an opportunity of
examine and reﬂect on the conditions – intellectual categories,
moral principles, geopolitical models, medical practices and other
techniques – that make it possible to think about chronic diseases
as a problem for developing countries today. Second, a concernwith
‘care’ can help analyse and question contemporary NCD policies in
the global South and their consequences by drawing on a tradition
of social justice and human rights. Third, a focus on ‘culture’ offers a
grid of analysis to explore and make sense of how both unhealthy
lifestyles and public health policies associated with NCDs are
translated, resisted and transformed when they travel from the
global North to the global South. The six papers in this special issue
represent important contributions to these themes while also
highlighting the incredibly broad range, depth and complexity of
concerns that the politics of NCDs invoke. These concerns then
signpost future research agendas across the social sciences that are
attuned to the current tenor of policy debates as well as shifts in the
landscape of global health funding and programmatic priorities that
will be drawn out at the end of this introduction.2. The problematisation of chronic disease in the global South
For the most part, public health experts are concerned with
conﬁrming that NCDs are an issue for LMICs and articulating
possible solutions. In contrast, more critically minded researchers
are interested in exploring the conceptual, political and material
conditions that make it possible to identify and think about
chronic diseases as a problem of development today. Such an ap-
proach draws on the notion of ‘problematisation’ developed by
Foucault (1984; 1988) and others (e.g. Rabinow and Rose, 2003;
Hacking, 2002; Miller and Rose, 2008; Koopman, 2013). For these
scholars, ‘problems are not pre-given, laying there waiting to be
revealed’, but ‘have to be constructed and made visible’ through ‘a
complex and often slow process’ (Miller and Rose, 2008, p.14). It is
this ‘process of problematisation’ that they are keen to analyse in
order to understand ‘how and why certain things (behaviour,
phenomena, processes) became a problem’ (Foucault, 1984, p.17).
This means exploring the ‘ensemble of discursive and non-dis-
cursive practices that make something enter into the play of true
and false and constitute it as an object of thought, whether in the
form of moral reﬂection, scientiﬁc knowledge or political analysis’
(Foucault cited in Rabinow and Rose, 2003, p.xviii-xix). Put dif-
ferently, it involves studying the progressive development and
assemblage of the scientiﬁc, moral and political rationalities, in-
stitutions, practices and techniques that make it possible to think
of certain things as a problem today.
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in the global South are not a pre-given reality waiting to be re-
vealed through ever more sophisticated epidemiological in-
vestigations but a problem that has been made thinkable through
the progressive articulation of a complex assemblage of geopoli-
tical categories, modernisation theories, biomedical practices and
international networks of experts in health and development (Ong
and Collier, 2008). We sketch here a tentative genealogy of some
of these rationalities, practices and networks that make it possible
to conceive of chronic diseases as a problem of development today.
An important, early moment in such a genealogy has to be the
elaboration of the notion of ‘health development’ in the post-
World War II period (Walt and Rifkin, 1990). This was a period
marked by the dismantling of the old colonial empires and the
birth of the ‘Third World’ articulated through the theories and
practices of development (Escobar, 1995). At ﬁrst, the new devel-
opment experts did not attach much importance to health. Indeed,
for them, development was about economic growth and physical
capital like roads, railways and industries. It is only from the 1960s
onwards that they began to recognise that development was also
about poverty alleviation and human capital. For the most part,
this meant investing in education and healthcare systems so as to
improve the quality and quantity of the labour force and bolster
national productivity (Finnemore, 1997).
Another, critical step in the framing of chronic disease as a
development issue was the articulation of the concept of chronic
disease itself. As Armstrong (2014) has argued, this concept only
came to prominence in the postwar period (cf. also Weisz, 2014a).
The elaboration of this concept made it possible to bring together
and view disorders such as cancer and heart ailments – which
until then had been thought to be the product of the natural
process of ageing and, as such, outside the realm of medicine – as
part of a new diagnostic category: diseases with an aetiology of
multiple, lifestyle-related risk factors that had a lasting impact on
someone's capacity to function normally. As Armstrong (1995) also
shows, this new diagnostic category came together with a new
model of medicine – surveillance medicine – that progressively
displaced pathological medicine from the 1950s onwards. Patho-
logical medicine was about investigating the physiological lesion
in the body of the patient in the hospital through clinical ex-
aminations, laboratory analyses and post-mortems (Foucault,
1976). In contrast, surveillance medicine was concerned with
identifying possible risk factors of future illness through regular
medico-social surveys and screening programmes of everyone in
the community, both the ill and the seemingly healthy. Unlike
pathological medicine, it also assumed a responsible patient who
actively engaged in his or her surveillance, education and care,
which comprised healthy lifestyles promotion campaigns,
screening tests and life-long drug regimens (Petersen and Lupton,
2000).
For most public health experts, chronic diseases and the de-
veloping world were long thought to be mutually exclusive, with
chronic diseases deemed to be the preserve of the rich, in-
dustrialised countries of the North while the major concern for the
South was infectious diseases and malnutrition (Bryant, 1969;
Brockington, 1985). In the minds of these experts, these differ-
ences in disease patterns were closely related with the demo-
graphic and socio-economic changes associated with modernisa-
tion. Perhaps the most inﬂuential account of this relationship
between disease and modernity was Abdel Omran's notion of
epidemiological transition. In Omran's terms, so-called ‘developed
countries’ had undergone an epidemiological transition and en-
tered the ‘Age of Degenerative and Man-Made Diseases’, which
was not only characterised by chronic diseases but also by: low
fertility, high life expectancy and ageing populations; economies
articulated around technology and mass consumption; as well asrationality, nuclear families and high living standards (Omran,
1971, p.516–517). In contrast, ‘undeveloped’ societies, he posited,
had yet to complete this transition and were still in the ‘Age of
Pestilence and Famine’ deﬁned not only by infectious diseases and
malnutrition but also by: high fertility, high mortality and young
populations; economies mixing subsistence farming with early
industrialisation; as well as traditional values, extended families
and poor, unsanitary living conditions (ibid.).
These different disease patterns and development levels were
further associated with differing healthcare systems. While sur-
veillance medicine was the dominant paradigm in North America
and Europe, the notion of primary health care (PHC) enshrined in
the Declaration of Alma Ata prevailed across the Third World
(Fassin, 2000; Cueto, 2004). After independence, developing
countries quickly realised that the healthcare systems inherited
from colonial times and based around the hospital and eradication
campaigns against tropical diseases were not appropriate to their
situation: hospitals, usually located in cities, were not accessible to
the rural poor that made up most of their population; eradication
campaigns were associated with authoritarian practices that jarred
with the spirit of decolonisation; and Western medical technolo-
gies were too expensive. PHC was developed as an alternative
model of healthcare tailored to the speciﬁc needs of the Third
World. It promised to offer essential healthcare made accessible to
all citizens via a network of rural health workers and centres and
characterised by community participation, an emphasis on pre-
vention and simple, cheap technologies. While the programmes
put in place to operationalise the PHC ideal varied across the de-
veloping world, they tended to concentrate on communicable
diseases and child and maternal health issues, including: oral re-
hydration therapy for diarhoea; family planning; nutrition; and
mass immunisations against major infectious diseases like measles
and diphtheria (Mull, 1990).
This way of thinking, which deemed chronic diseases and the
developing world as mutually exclusive and associated the latter
with infectious diseases, maternal and child health, malnutrition
and PHC remained predominant until the turn of the century. The
Millennium Development Goals, for example, owed a lot to this
style of reasoning, not least by viewing health as critical to de-
velopment and by constraining its health-related efforts to ma-
ternal and child health, infectious diseases and malnutrition. But,
from the late 1970s onwards, an increasing number of reports
from physicians and mostly small, hospital-based epidemiological
surveys in LMICs showing a growth in the number of patients
suffering from NCDs began to challenge this way of thinking
(Phillips, 1990; Reubi, 2013). Unsurprisingly, this gradually led to
efforts to construe chronic diseases as a development issue. Of
course, the WHO did some work on chronic diseases in the Third
World, launching its Integrated Programme for Community Health
in Non-Communicable Diseases in a small number of developing
countries in the 1980s (Weisz, 2014a). But, it was the efforts of
economists and epidemiologists at the World Bank – especially
Dean Jamison's Health Sector Priorities Review, Richard Feachem's
work on the Health of Adults in the Developing World and
Christopher Murray's Global Burden of Disease Project – that
would prove to be the most inﬂuential in identifying chronic
disease as an issue for the global South and reconﬁguring the re-
lationship between development levels, disease patterns and
healthcare models (Feachem et al., 1992; Jamison et al., 1993;
Murray and Lopez, 1996).
There were many reasons for why the Bank's efforts proved to
be so inﬂuential. First, this was a time when the Bank's investment
in health-related projects grew exponentially, making it the
world's premier health institution and pushing the WHO to the
sidelines (Brown et al., 2006; Chorev, 2012). Second, the Bank's
experts articulated a new understanding of the relation between
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issue for LMICs. They suggested that one should stop classifying all
developing countries together and recognise instead their growing
economic and epidemiological diversity (Frenk et al., 1989; Jami-
son and Mosley, 1991). Speciﬁcally, complexifying Omran's model,
they recommended distinguishing between two groups of devel-
oping countries: (i) low-income, usually African or South Asian,
countries typiﬁed by infectious diseases and malnutrition; and (ii)
middle-income, mostly East Asian or Latin American, countries
characterised by a double burden of both infectious and chronic
diseases (Jamison and Mosley, 1991). It was this second group –
whose emergence was due to the success of existing PHC pro-
grammes at reducing infant mortality and changing patterns of
risk such as unhealthy lifestyles generated by rapid urbanisation
and rising incomes – that was the novelty and allowed the Bank's
specialists to associate developing countries and chronic diseases
for the ﬁrst time (Bobadilla et al., 1993; Jamison et al., 1993;
Mosley et al., 1993). Third, the claims about changing patterns of
disease and development made by the Bank’s experts seemed to
be supported by the new, allegedly more rigorous estimates of
worldwide mortality and morbidity generated by Murray’s Global
Burden of Disease project, something which was critical at a time
when evidenced-based approaches were becoming all the rage
(Murray and Lopez, 1996; Reubi, this issue). Fourth, the Bank's
experts ensured that the problem of NCDs in the global South
gained traction by linking it with a question that came to dom-
inate the political agenda in most developing countries after the
energy crises and global recession of the 1970s: how to ﬁnance
healthcare systems in the face of mounting national debts and
budgetary restrictions? (Rowden, 2009; Reubi, 2013). They did so
through the notion of double burden of disease burden char-
acteristic of the new, second group of developing countries, ar-
guing that it would substantively add to the ﬁnancial strain al-
ready impacting these countries’ healthcare systems (Frenk et al.,
1989; Jamison et al., 1993). Fifth, unlike the WHO, the Bank was
not wedded to PHC and was able to outline alternative healthcare
models (Chorev, 2012). In particular, it argued that PHC pro-
grammes, with their focus on rural populations, infectious diseases
and child and maternal health, had become too limited and called
for a new healthcare model articulated around rational policies,
epidemiological surveillance, cost-effective interventions focused
on prevention and, sometimes, privatisation (Mosley et al., 1990;
Birdsall and James, 1993).
Over the last ﬁfteen years, the Bank has shown less interest in
chronic disease and development, leaving the WHO and other
organisations like the NCD Alliance and The Lancet to take the lead
in this ﬁeld (Weisz, 2014b). As mentioned at the start of this in-
troduction, the numerous reports, action plans and scientiﬁc pa-
pers published by these organisations have further consolidated
and propagated the ideas of NCDs as a development issue. Of
course, these organisations have brought some of their own con-
cepts and idiosyncrasies – like the WHO's addition of a reworked
and weakened notion of PHC – to the way they frame this issue.
But, overall, the way they conceive chronic diseases in the global
South is strongly inﬂuenced by the analyses and ideas articulated
by the World Bank's experts during the 1980s and 1990s. To il-
lustrate, most of the documents on the topic published by these
organisations share the Bank's understanding that the relationship
between NCDs and development is a two-way process, with eco-
nomic growth generating unhealthy lifestyles and reducing
chronic disease prevalence critical to improving productivity (e.g.
WHO, 2010; UNDP, 2013). Likewise, most of these documents,
echoing the Bank, express the signiﬁcance of the NCD epidemic in
the global South through rigorous epidemiological data and em-
phasise the importance of using cost-effective health interventions
and public-private partnerships (e.g. Lim et al., 2007; WHO, 2013).3. Chronic diseases and the politics of care
A focus on problematisation is, of course, not the only critical
approach that can be used to make sense of current efforts to
tackle NCDs in the global South. Another, important lens through
which to explore these efforts is a critique characterised by a
concern with social justice and human rights (Benatar et al., 2003;
Benatar, 2005; Kleinman, 2010; Venkatapuram, 2010). This frame
points to the political importance of care to the ways in which we
approach NCDs across a number of domains. Speciﬁcally, the in-
vocation of social justice and human rights acts as a critique of
current approaches to NCDs in two ways. First, of the global health
community's selective deployment of the tools, techniques, funds
and interventions that permits the care of people. Second, of the
ability of the state to ensure the adequate care of its citizens. If the
ﬁrst critique calls the contemporary architecture of global health
into question (Farmer et al., 2013; Garrett, 2013), then the second
scrutinises the ability of this architecture to deliver sustainable,
effective and equitable health improvements on the ground (Be-
natar, 2005; Venkatapuram, 2010). The politics of NCDs in the
global South are thus bound into and directly shaped by the nat-
ure, delivery and critique of care by a variety of actors. The ability
and will to care, in turn, is shaped by the complex, multi-scalar
politics and resource ﬂows that condition so much of the global
health enterprise. Care implies a need for empathy, responsibility
and duty just as much as it does the fair distribution of medical
services and resources and the capacity to access and make use of
these (Kearns and Reid-Henry, 2009). It is therefore an essential –
if under-acknowledged – component of the politics of NCDs in
countries of the global South.
The capacity to care is constrained by a number of factors that
warrant further scrutiny. In the ﬁrst place, current efforts to ad-
dress chronic diseases in LMICs are indubitably limited by the very
delineation of NCDs themselves. This, in turn, draws attention to
the ways in which the global health enterprise is so often enacted
within a number of speciﬁc and siloed realms, with little structural
capacity to deal with the implications of the complex porosity of
deﬁnitional categories. For example, ‘the boundaries between
communicable and non-communicable diseases are often indis-
tinct’ (Farmer et al., 2013, p. 321). So, it could be argued that, with
the development of antiretroviral therapies, AIDS has become a
chronic disease that can be managed through life-long drug regi-
mens and changes in one's lifestyle. Similarly, some have argued
that cervical cancer, a current priority of the global health com-
munity, is more akin to a communicable disease given that it is
triggered by the sexually-transmitted Human Papilloma Virus
(HPV) and is now preventable through a vaccine (Livingston,
2012). There are, moreover, similar boundary problems with
mental health issues like depression that are excluded from the
ofﬁcial NCD deﬁnition but yet seem to ﬁt the notion of a disease
that has a lasting impact on someone's capacity to function in
society (WHO, 2010). The notion of NCD also partakes in the
‘mistake of pitting one set of pathologies against another’ for at-
tention and funding from the global health community, instead of
promoting an approach to public health policy and practice that is
intersectoral and holistic (Farmer et al., 2013, p.322). Interestingly,
this division and fragmentation is also encouraged by the focus on
discrete, cost-effective health interventions developed by the
World Bank at the end of the 20th century and taken over by the
WHO and others over the last 15 years.
Another issue relates to the capacity of the state to provide
adequate care for its citizens and, moreover, the consequences of
this for the sustainability of global health programmes (Marmot
et al., 2008). Failure in this domain is both deﬂected and reinforced
by the lack of focus on the social determinants of NCDs and the
role of mounting inequalities in entrenching these. Moreover, the
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Yach and Beaglehole, 2004) and rapid urbanisation (Mitlin and
Satterthwaite, 2012; WHO/UN-HABITAT, 2009) have unsettled the
assumptions inherent within the epidemiological transition
model. Now, households are gripped not just by the ‘double bur-
den’ of disease (Bygbjerg, 2012), but in some cases, a ‘triple’ or
even ‘quadruple burden’ that also includes injuries and violence,
as well as perinatal and maternal diseases (Bradshaw et al., 2003).
Crucially, the characteristics of these burdens vary not just be-
tween countries, but also within them and at ever-ﬁner geo-
graphic scales. Even within one household, for example, there
might be underweight, malnourished family members living
alongside equally malnourished obese relatives (Doak et al., 2004).
It is important then to consider the social determinants of this
complicated and multi-layered disease burden: poverty, inequal-
ity, quality of housing, access to sanitation, unemployment, edu-
cation, transport, food security, the nature of healthcare provision
and environmental degradation. It is these structural, economic,
political and social drivers that largely condition the dynamics of
the four main risk factors for chronic disease: diet, exercise, alco-
hol and tobacco (WHO, 2005). Yet, while the proportion of people
living in poverty may have fallen (United Nations, 2013), rates of
both inequality and, perhaps even more importantly, inequity,
within many countries is accelerating (OECD, 2011). This means
that while advances in medical science remain essential to redu-
cing mortality and morbidity, there is also an absolute imperative
for ‘economic and social policies that would improve basic living
conditions’ for all household members in LMICs (Benatar et al.,
2003, p. 110). Moreover, it must also be acknowledged that while
urbanisation creates new behavioural risks for those living in ci-
ties, in many LMICs, it also produces a profound care gap in which
older family members are left in rural areas without either ade-
quate health infrastructure or family networks to care for them in
times of illness (Livingston, 2003). These transitions, in turn, test
the capacity of the state just as much as the current machinery of
global health.
With its overwhelming focus on single diseases and techno-
cratic solutions, global health does offer a model of care, but it is
one that can often be problematically short-lived and partial
(Garrett, 2007). It can also be outcomes rather than process-or-
ientated. This raises the question of the type of care global health
endeavours to provide and for whom. Indeed, the degree to which
the mechanisms of global health penetrate broader social struc-
tures and, as a result, the determinants of health, is a question that
is infrequently asked and nowhere near being solved. Under
conditions where global health activities have supplanted the re-
sponsibilities of the state, there is the danger that this may start to
precipitate ‘a striking culture of indifference to afﬂiction present in
areas of extreme inequality’, which, in turn, ‘facilitates a patho-
genic biosocial spiral of socioeconomic exclusion and deteriorating
health’ (Nguyen and Peschard, 2003, 448; see also Farmer, 2005;
Quesada et al., 2011). Thus, while many countries of the global
South have witnessed meteoric climbs in their middle classes, the
gulf between rich and poor has only widened. Across the global
South, there are also mounting inequities between state and pri-
vate healthcare provision, the distribution of essential medical
technologies, drugs and expertise as medical professionals seek
employment in the global North, the cities of Asia and the Gulf
(Mills et al., 2011; Parry et al., 2015). This necessarily means a si-
tuation where ‘the rich, although increasingly shielded from most
disease threats, are able to purchase better health’ (Nguyen and
Peschard, 2003, 449) and may actually only rarely come into direct
contact with global health programmes. Moreover, when the
richest can access healthcare elsewhere, this does little to either
inculcate a broader ethic of care or to bolster support for efforts to
address the wider social determinants of health (Hall, 2011). As aresult, social justice and human rights remain a persistent absence
in the politics of NCDs in the global South.
This absence is further reinforced by the fracturing of the social
solidarities that have traditionally underpinned an ethic of care in
the face of global change. This in turn reveals a further, painful
irony at work in efforts to tackle NCDs in the global South. NCDs
require not only the care of others, but also necessitate care of the
self, especially in relation to the four major lifestyle risk factors.
This need is occurring just as the traditional state-centred me-
chanisms of care and the will to care may be being eroded, not
least because of the reforms associated with structural adjustment
policies (Rowden, 2009). NCDs require adherence to both pre-
vention and treatment regimes. Both are amenable to some degree
of individual control (such as not smoking or drinking in mod-
eration), but are equally often determined by the structural factors
underpinning the distal pathogenic effects of inequality. These can
erode real choices as well as the capacity to make reasoned
choices. Further complicating care, treatments for NCDs, even if
available, may be expensive or their supply intermittent. Treat-
ment regimes may require lifetime adherence (e.g. statins for high
cholesterol), certain levels of competence (e.g. diabetes blood su-
gar testing and insulin therapy), expensive technologies or com-
plex surgical techniques (e.g. MRI scanners, laser surgery) or basic
palliative medications such as analgesics that are unavailable
(Beaglehole et al., 2011, 1442). Moreover, where infectious disease
and NCDs coexist, as they so often do in the global South, existing
poor health, compromised immunity or episodic illness may un-
dermine the capacity to undertake either prevention or treatment
activities. Not only may this ignite conditions under which the
rhetoric of individual blame may be invoked, but it also ensures, as
Livingston's (2005, 2008, 2012) exemplary work in Botswana has
explored, that people need more care, often earlier in their lives
and the consequences of illness can be catastrophic in terms of
economic and social disenfranchisement.4. Chronic diseases and the politics of culture
Another, third way to critically examine the politics of NCDs in
the global South is through the lens of ‘culture’. This immediately
begs the question: what is meant here by culture? Do we mean
culture in the normative sense, as a ‘thing’ (for example, a set of
health-related practices, beliefs or behaviours) that is shared by a
speciﬁc cultural group or within a geographical space that is ar-
gued to have dominant cultural norms (Dutta, 2008)? It is cer-
tainly the case that such a normative perspective has been mo-
bilised in analyses of non-communicable diseases in the global
South as elsewhere; especially those that highlight the importance
of lifestyle risk factors. Such analyses are often framed by a dif-
ferent transition model to the ones we have already discussed; to
the epidemiologic and health transition models we can add the
idea of the nutrition transition (Popkin, 1994). This latter model
emphasises the relationship between levels of economic growth or
development and patterns of dietary behaviour. As Drewnowski
and Popkin (1997) explain, diets at one time primarily associated
with the rich industrialised nations of the global North – the so-
called ‘western’ diet, which is high in fats, especially meat and
milk products, saturated fats and sugars – are no longer regarded
as being spatially ﬁxed. Put simply, relatively early studies into the
structure of global diets in the 1960s and 1970s suggested that as
GNP per capita rises within nations so too does the consumption
of foods associated with the western diet. More recent analyses,
such as that offered by Drewnowski and Popkin (1997; see also
Pingali, 2007; Kearney, 2010), add further layers of understanding
to this fairly simplistic model by suggesting that a host of other
factors, including urbanisation, global food advertising and
D. Reubi et al. / Health & Place 39 (2016) 179–187184marketing and associated shifts in socio-cultural practice, also play
an important role in this transition (Hawkes, 2006).
Of particular concern here is the question of the rapidity of the
nutrition transition and the importance of culture to it; as Chopra
et al., (2002, p. 954; cf. also: WHO, 2002; WHO/FAO, 2003) re-
marked, ‘[a]larm has been expressed about the rapid spread of the
fast food culture, perhaps exempliﬁed most visibly by McDonald's’.
There is a tendency in analyses that draw on culture in this way to
treat it as a ‘thing’ that invades or colonises other, often by im-
plication indigenous or ‘traditional’, cultural practices; as Uusitalo
et al. (2005, p. 608) explain, ‘the diffusion and adoption of Western
culture in other places is often termed “Westernisation”, whereby
societies and individuals adopt particular ideas and practices from
more economically developed and commercialised countries’. So,
for example, studies such as theirs point to the replacing of ‘in-
digenous’ foods with ‘western’ ones: rice, ﬁsh and vegetables for
eggs, dairy and meat. This surprisingly imperialist vision of an
invasive western culture mirrors long-standing concern with the
impact of acculturation on the food habits of migrants; as shown,
for example, in relatively early studies of migration, dietary change
and chronic heart disease in 1960s USA (cf. Syme et al. 1965;
Marmot and Syme, 1976).
Such analyses of cultural transition, here relating to dietary
behaviours, highlight the disruptive tendencies of social change
brought about by processes such as rapid urbanisation or the
globalisation of cultural practices and their often negative inﬂu-
ence on population health (Szreter, 1999). This is certainly an
important area for further academic enquiry especially in the
many and diverse countries that make up the global South. Indeed,
as Whyte (2012) notes, most ‘cross-cultural’ studies of this kind
have been carried out in the multi-ethnic settings of high-income
countries in the global North. However, it is not the only way in
which we might approach the question of culture as it relates to
the politics of NCDs. Crawford's (1984) inﬂuential essay on cultural
approaches to health is useful here. As he argues, the body is a
‘cultural object’; one that provides a ‘powerful medium through
which we interpret and give expression to our individual and so-
cial experience’ (Crawford, 1984, p. 60; see also Lupton, 2012).
Bodies are differentially constituted as healthy, diseased, risky and
so on across a range of media and with consequences that are felt
at different spatial scales as well as at the level of individual
bodies. While this is perhaps especially so with regards infectious
or contagious bodies, all bodies that are understood as out of
control or outside of socially constituted notions of normality –
obese ones, depressed ones, cancerous ones, psychotic ones, in-
toxicated ones – are those upon which political and ideological
optics are focused (Craddock and Brown, 2009; Brown et al., 2012).
A further illustration of the importance of engaging critically
with the politics of culture and health that emerge here comes
from the discourse of the contemporary obesity epidemic. Across
the social sciences, there is a lively and often contentious debate
relating to Foucault's concepts of biopower and biopolitics and
how they might be drawn upon in critical analyses of non-com-
municable diseases in general and obesity more speciﬁcally (e.g.
Wright and Harwood, 2009; Lupton, 2013). The participants in this
debate not only contest the science of obesity (e.g. Gard and
Wright, 2005; Guthman, 2011) but, more importantly here, they
critique the pathologisation of fatness and an associated govern-
mental impulse that prioritises the production of bodies that
conform to cultural norms regarding size and shape as well as to
contemporary public health imperatives relating to individual and
population health (e.g. Evans, 2006; Evans and Colls, 2009; Full-
agar, 2009; Herrick, 2011). As Bethan Evans and Rachel Colls argue,
such an impulse is biopolitical in that individuals are the subjects
of ‘surveillance, punishment and training’ and relates to Foucault's
broader understanding of biopower because the discoursesurrounding obesity is directed at ‘man-as-species’ and is con-
cerned more generally with the health of populations (Foucault
cited in Evans and Colls, 2009, p. 1055).
Evans (2010) extends this reading of the biopolitics of obesity
in a subsequent essay discussing notions of threat and pre-emp-
tive politics as they relate to the body, the population and the
nation. As she argues, the ‘war’ on obesity that has developed in
the high-income countries of the global North, which is a war on
speciﬁc types of bodies as much as it is a war on the environments
that help to produce them (Guthman, 2011), is concerned pri-
marily with the threat that the ‘matter of bodies’ pose in the future
(Evans, 2010, p. 22). Evans distinguishes here between the public
health logics of prevention and pre-emption and focuses on inter-
ventions directed at the ‘bodies of the future’: children (Evans,
2010, 30). Her argument is that where the western tradition of
public health has in the past concerned itself with the prevention
of known and calculable risks to health, it is now more focused
with taking pre-emptive action in the face of futures that are less
certain, less knowable. As she argues, obesity policy is ‘reliant on
the temporal gap between onset of risk factor and onset (or not) of
ill-health. This gap provides an opportunity for pre-emptive ac-
tion…’ (Evans, 2010, p. 30).
There are two key points to take from the above discussion.
Firstly, if we only treat culture normatively in our analyses of NCDs
in the global South, as there has been a tendency to do, we risk
obscuring the political contestation that arises around speciﬁc
bodies and the (western) practices that have rendered them pro-
blematic. Yach et al. (2006) suggest there is a threat inherent in the
importation of western medical responses; for them, it relates to
the pharmaceuticalisation of public health as well as to the re-
liance on procedures such as bariatric surgery (cf. Whitmarsh,
2013). Arguing from a health economics perspective and for more
emphasis on evidence-based prevention strategies, they suggest
such interventions risk the vitality of entire health systems as
money is diverted to expensive and unaffordable treatments. We
would argue this is not the only ‘threat’ that needs critical atten-
tion. To it we would add the threat posed by neoliberal ideologies
that have underpinned the response to NCDs in the global North
and which see care for certain bodies not only as an ‘excessive cost’
in the present but as an unacceptable burden on the future
(Guthman, 2011, 54). Secondly, and more brieﬂy, the above dis-
cussion challenges us to consider more seriously and much more
critically the emerging preventive and pre-emptive strategies that
are being put in place in the global South to assure against the
apparent threat posed by western cultural practices.5. An outline of the special issue
The six papers of this special issue help shed light, in varying
ways, on our respective concerns with problematisation, care and
culture within the politics of NCDs in the global South. Reubi's
(this issue) paper explores how epidemiological models used to
problematise smoking in developing countries are building on
notions of time and space associated with postwar theories about
modernisation and progress. In this reading – favoured by tobacco
control activists – development and, by extension, the kinds of
“globalised” culture that are presumed to be the hallmark of
economic growth become proxies for epidemiological risk. Here,
development and culture are constructed as speciﬁc and serious
threats to public health, with political intervention the favoured
solution. Criticism of the simplistic readings of culture that can
dominate the politics of NCDs is also a feature of Smit et al.'s (this
issue) paper in which they explore the recursive relationships
between the built environment and the experience of chronic
disease in the context of Khayelitsha, one of Cape Town's poorest
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the problem frames of the global NCD agenda – mental health and
the entanglements of urban environments with upstream de-
terminants of health. The gross inequalities in everyday life within
cities not only condition the likelihood of suffering from chronic
disease, but also the shape and nature of that suffering. Cultural
coping mechanisms, in turn, can be severely compromised by the
nature of places and their use. Smit et al. draw attention to the
problems of food purchasing and storage, of being physically active
and of the depression and stress that emerge from living with the
perpetual (fear of) crime and violence. Coping, Smit et al. argue,
will only be enhanced through attention to the drivers of risky
environments, issues that remain silent in a politics of NCDs that
would prefer to blame the failings of culture than acknowledge the
complicity of the state in producing risk.
This critique is also a feature of Glasgow and Schrecker's (this
issue) paper in which they argue that the political imaginaries of
global health, shaped as they are by inherently neoliberal ideolo-
gies, purposefully divert attention from both the social and poli-
tical economic determinants of NCDs. Instead, they place respon-
sibility for NCDs and their prevention in the hands of individuals,
rendering care a matter of successful cultural behavioural inter-
ventions. The concern with individual choice, responsibility and
empowerment also represents the hope that new, self-governing
subjects can be formed that, in turn, can exercise a culture of self-
care. Such a culture is essential for the success of most con-
temporary NCD prevention and treatment strategies, yet so much
critical social scientiﬁc analysis demonstrates just how proble-
matic these political aspirations are. For example, MacDonald's
(this issue), Bunkenborg's (this issue) and Whyte's (this issue)
papers all engage with the politics of NCDs through the experi-
ences of largely ‘improvised’ (Livingston, 2012) treatment options
for breast cancer and diabetes available in India, China and Uganda
respectively. These papers speak directly to each other in their
concern with the new forms of biosociality and therapeutic citi-
zenship that arise in the need to care for those suffering with
chronic diseases in places where the medical treatment provided
by public hospitals, charities and private clinics is either in-
sufﬁcient or at odds with local cultural models of health and ill-
ness. For MacDonald and Whyte, this care takes the form of expert
patients and patient groups that help mediate the often in-
adequate relationship between doctor and patient and provides
the empathy and information needed to plug gaps in the existing
provision of care. For Bunkenborg, these new forms of sociality
and citizenship do not only involve expert patients and patient
groups but are also mediated through the commercial world of
diabetes treatments and technologies. In his example of China, the
doctor-patient relationship is often fraught with mistrust, pro-
viding an opportunity for a cacophony of private enterprises to
bring the hope of diabetes self-management through a range of
products and drugs. In each of these examples, the experience of
NCDs, the cultural formations that emerge from them and the
demand for care are inextricable from the complex and despe-
rately uneven public-private patchwork of medical services. In-
adequate care is rarely a matter of cultural failing, despite the
blame tendencies of individualised behavioural framings of NCDs.
In understanding the interweaving of politics, care and culture in
the problematisation of NCDs in the global South it is hoped that
this collection of papers will open up new conversations about
these issues and help us think how politics and policies might be
reshaped in ways that enhance their ability to alleviate human
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